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Astrocyteside (Aβ) is known to induce cytotoxic effects and to damage cell functions in
Alzheimer's disease. However, mechanisms underlying the effects of Aβ on cell membranes have yet to be
fully elucidated. In this study, Aβ 1–42 (Aβ42) was shown to cause a temporal biphasic change in mem-
branes of astrocytic DITNC cells using ﬂuorescence microscopy of Laurdan. Aβ42 made astrocyte membranes
became more molecularly-disordered within the ﬁrst 30 min to 1 h, but gradually changed to more
molecularly-ordered after 3 h. However, Aβ42 caused artiﬁcial membranes of vesicles made of rat whole brain
lipid extract to become more disordered only. The trend for more molecularly-ordered membranes in
astrocytes induced by Aβ42 was abrogated by either an NADPH oxidase inhibitor, apocynin, or an inhibitor
of cytosolic phospholipase A2 (cPLA2), but not by an inhibitor of calcium-independent PLA2 (iPLA2). Apo-
cynin also suppressed the increased production of superoxide anions (O2−) and phosphorylation of cPLA2
induced by Aβ42. In addition, hydrolyzed products of cPLA2, arachidonic acid (AA), but not lysophosphati-
dylcholine (LPC) caused astrocyte membranes to become more molecularly-ordered. These results suggest
(1) a direct interaction of Aβ42 with cell membranes making themmore molecularly-disordered, and (2) Aβ42
also indirectly makes membranes become more molecularly-ordered by triggering the signaling pathway
involving NADPH oxidase and cPLA2 in astrocytes.
Published by Elsevier B.V.1. IntroductionIncreased production of amyloid-β peptides (Aβ) and their deposi-
tion as amyloid plaques in brains have been implicated in the patho-
genesis of Alzheimer's disease (AD). In fact, the soluble oligomeric
form of Aβ is cytotoxic to neurons and glial cells [1]. The cleavage of
amyloid precursor protein by γ-secretase at the transmembrane do-
main demonstrated a hydrophobic property of the peptide at the
carboxyl terminal and their ability to bind lipids [2]. Studies also
demonstrated the ability of Aβ to perturb membrane and alter sy-
naptic functions, such as calcium signaling, activity of enzyme, and
lipid transport [3–6]. It has also been reported that the alteration of
synaptosomal membrane ﬂuidity induced by Aβ may underline im-
pairment in memory and learning [7]. However, the mechanism
underlying the effects of Aβ on cell membrane properties has yet to
be elucidated. In this study, we demonstrate that phospholipase A2
(PLA2) is involved in the mechanism underlying the effects of Aβ42
oligomers on cell membrane phase properties.llins St, Columbia, MO 65211,
.V.Phospholipases A2 (PLA2) are enzymes catalyzing the cleavage of
fatty acids from the sn-2 position of phospholipids to produce free
fatty acids and lysophospholipids [8,9]. PLA2 are generally grouped
into three major types, the Ca2+-dependent group IV cytosolic PLA2
(cPLA2), the Ca2+-independent group VI PLA2 (iPLA2) and the Ca2+-
dependent group II secretory PLA2 (sPLA2) [10]. PLA2 not only plays a
role in maintenance of cell membrane integrity, they are also critical
in regulating the release of arachidonic acid (AA), a precursor for
eicosanoids [10]. PLA2 has been implicated in a number of neuro-
degenerative diseases including AD [11,12]. A marked elevation in
cPLA2 in the nucleus basalis and hippocampal regions of the AD brain
has been observed [13–15]. Excessive PLA2 activity disrupts mem-
brane ﬂuidity and alters composition and subsequently, activity of
membrane-dependent proteins, such as Na–K–ATpase, beta2- and
alpha2-adrenergic receptors, norepinephrine and serotonin uptake,
and imipramine binding [16]. Our previous study demonstrated that
Aβ42 oligomers increase localization of phosphorylated cPLA2 with
mitochondria in astrocytes, and that activations of both cPLA2 and
iPLA2 are the key steps in Aβ42 oligomer-induced mitochondrial dys-
function in astrocytes [17]. Therefore, it is reasonable to hypothesize
that oligomeric Aβ perturbs cell membrane properties not only
through direct interaction with or insertion into cell membranes, but
also through stimulating signaling pathways involving PLA2.
2513J.B. Hicks et al. / Biochimica et Biophysica Acta 1778 (2008) 2512–2519In this study, we applied ﬂuorescence microscopy of an environ-
mentally sensitive probe, Laurdan, integrated into membranes of as-
trocytic DITNC cells, to characterize the changes in membrane
molecular order induced by oligomeric Aβ42. Inhibition studies dem-
onstrated the involvement of NADPH oxidase and cPLA2 in Aβ42-
induced membrane molecular order changes in DITNC cells.
2. Materials and methods
2.1. Materials
Dulbecco's modiﬁed Eagle medium (DMEM), F12 medium, Iscoves's
modiﬁed Dulbecco'smedium (IMDM), phosphate-buffered saline (PBS),
Tris-buffered saline (TBS), trypsin-EDTA, streptomycin-penicillin, and
fungizone were from Invitrogen (Gaithersburg, MD). Fetal bovine
serum (FBS) was from US Bio-Technologies (Parkerford, PA). Methyl
arachidonyl ﬂuorophosphonate (MAFP) and (s)-bromoenol lactone
(BEL) were from Cayman Chemical (Ann Arbor, MI). Rabbit polyclonal
cPLA2 and phosphorylated-cPLA2 (Ser505) antibodies were from Cell
Signaling Technology (Beverly, MA). 6-dodecanoyl-2-dimethylamino-
naphthalene (Laurdan), and dihydroethidium (DHE) were from Invitro-
gen (Eugene, OR). Bovine serum albumin (BSA), poly-D-lysine,
arachidonic acid (AA), lysophosphatidylcholine (LPC), phorbol myri-
state acetate (PMA)andapocynin (Apo)were fromSigma (St. Louis,MO).
Aβ1–42 (Aβ42) and Aβ42–1 peptides were purchased from American
Peptide Company, Inc (Sunnyvale, CA).
2.2. Cell culture
Immortalized rat astrocytes (DITNC) were purchased from ATCC
(Rockville, MD., USA). Cells were maintained at 37 °C in a CO2
humidiﬁed incubator. DMEM culture medium supplemented
with 10% of fetal bovine serum, 1% of penicillin/streptomycin
(100 U/100 mg/ml) and 1% of fungizone (250 mg/ml) was fed to
the cells every 48 h. When cells grew to conﬂuency, they were
subcultured to new ﬂasks or dishes accordingly. In preparation for
subculture, cells were washed twice with PBS and then incubated
with 3 ml of 0.05% Trypsin-EDTA at 37 °C for 5 min. Culture medium
was added to stop the trypsin-EDTA enzyme reaction and cells were
then sedimented by centrifugation at 2000 rpm for 10 min. After
discarding the supernatant, cells were resuspended in the same
culture medium mentioned above and seeded to desired dishes or
plates according to experiment condition at 3×104/cm2 density.
Experiments were performed when cells achieved approximately
70–80% conﬂuency.
2.3. Preparation of oligomeric Aβ42
Aβ42 was obtained from American Peptides and its oligomeric
formwaspreparedaccording to theprotocol describedbyDahlgrenet al.
(2002) [18]. Brieﬂy, the peptide (1 mg) in powder formwas dissolved in
200 μL of hexaﬂuoro-2-propanol (HFIP) and the solution was aliquoted
into Eppendorf tubes. Organic solvent was removed using a speed
vacuum apparatus. The Aβ ﬁlm left in the tube was resuspended in
DMSO and further diluted in Ham's F12 medium to make a 100 μM
solution. The solution was incubated at 4 °C for 24 h prior to use. As
negative control, Aβ42–1 (American Peptides) was processed similarly.
Electrophoretic analysis of Aβ42 indicated a similar proﬁle with
oligomers in the preparation as described by Dahlgren et al. (2002) [18].
2.4. Cell treatment
DITNC cells were grown on polylysine-coated glass coverslips to
approximately 60% conﬂuency. Before the addition of necessary re-
agents, cells were incubated with a serum-free medium containing
DMEM overnight. Cells with/without pretreatment of inhibitors (e.g.MAFP, BEL and apocynin in DMSO) for 1 h were treated with the
desired concentration of stimulators (e.g. oligomeric Aβ42, and PMA
in PBS; AA and LPC in EtOH) at 37 °C.
2.5. Preparation of laurdan-labeled vesicles made from rat whole brain
lipid extract
Lipids in rat brains were extracted following the procedure de-
scribed by Zhang and Sun [19]. Brieﬂy, brain tissue was homogenized
in 10 ml of PBS and 40 ml of chloroform-methanol (2:1 v/v) was
added. The mixture was centrifuged at 2000 g for 10 min. The lower
organic phase containing the lipids was ﬁltered through a Pasteur
pipette column packed with glass wool and anhydrous Na2SO4. The
lipid extract was collected and stored at −20 °C until use.
To prepare Laurdan-labeled vesicles, ∼0.001 mol% of Laurdan
was added to brain lipids dissolved in chloroform-methanol (2:1 v/v)
solvent. The preparation of vesicles was accomplished by electro-
formation as described in Lee et al. (2001) [20].
2.6. Fluorescence microscopy of laurdan-labeled cells and visualization
of membrane molecular order
A membrane environmentally sensitive probe, Laurdan, was ap-
plied to characterize phase properties (i.e., molecular order) of
plasma membranes in cells. This compound has been applied to
detect phase transitions of different lipid systems as well as natural
membranes [21,22]. Based on the parameters introduced by Parasassi
et al. [21,22], generalized polarization (GP) of Laurdan is deﬁned as:
GP=(IB− IR)/(IB+ IR), where IB and IR are the intensities at 440 nm
and 490 nm respectively with a ﬁxed excitation wavelength of
350 nm. A higher GP indicates a more molecularly-ordered mem-
brane, and a lower GP indicates a more molecularly-disordered
membrane. Also, it is believed that laurdan GP is the measure of the
polarization or water partition at the membrane core near the head-
group interface, where the ﬂuorescent moiety of Laurdan (i.e. the
naphthalene group) should be located based on its chemical struc-
ture. However, the Laurdan GP should prove to reﬂect the overall
local membrane order, as GP values have been found to be corre-
lated well with the bending rigidity and transition temperature of
various bilayer membranes from typical phospholipid vesicles to
ultra-thick diblock copolymer membrane vesicles, suggesting that
GP measurements for studying membrane order are not affected by
membrane thickness [23]. In addition, it is important to be aware of
the basic concept of Laurdan GP that Laurdan GP indicates defects
in molecular packing of bilayer membranes which accommodate
water molecules (i.e. water partition).
After treatment at 37 °C, cells attached on glass cover slips were
washed twice with PBS and incubated with DMEM containing 1%
Laurdan for 15 min. Excess Laurdan was removed by washing cells
three times with PBS. The cover slips were then transferred to a
Bioptechs FCS2 Focht live-cell thermal chamber (Butler, PA) ﬁlled
with phenol red free DMEM medium, in which temperature was
maintained at 37 °C. Laurdan has been proved to preferentially in-
tegrate into plasma membranes with this protocol [24].
Fluorescence microscopy of Laurdan labeled cells was accom-
plished with a Nikon TE2000-U inverted microscope with a 60×, NA
1.4 oil immersion objective lens. A dual view micro-imager was
installed to the emission port of the microscope, which allowed the
acquisition of a pair of ﬂuorescent images from a sample simulta-
neously at the emission wavelengths of 446 and 499 nm with a
46 nm bandwidth. These pairs of ﬂuorescent images were used to
calculate the local GP values of the cells in the pixel basis. The local
GP values were then used to reconstruct a GP-mapped image for
direct visualization of local membrane phase properties in cells.
To compute spatially-distributed GP(x,y) for constructing GP-
mapped images by pseudo-color representation of GP(x,y), paired
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processed as follows: (1) convolution of both images with a Gaussian
kernel to reduce noise; (2) computation of the denominator by pixel-
wise addition of both images; (3) obtaining thresholds of the result
using Otsu's method to separate Laurdan-stained regions from the
background; and (4) computation of GP(x,y) on a pixel-by-pixel basis
with the additional condition that the resulting pixel is zero if the
thresholded denominator is zero.
2.7. Measurement of superoxide anion production in astrocytes
Dihydroethidium (DHE) was used to determine superoxide anion
(O2−) production following a modiﬁed protocol as described by
Chapman et al. [25]. Upon contact with superoxide anions, oxoethi-
dium, a highly ﬂuorescent product from the oxidative reaction of
DHE, binds to DNA, causing an increase in ﬂuorescent intensity of the
cell nuclei. In this study, DITNC cells were grown on 8-well chambers
and serum starved overnight. Cells were rinsed twice with warm
serum-free and phenol red-free (PR-Free) DMEM and incubated
with DHE (5 μM) in PR-free DMEM at 37 °C for 30 min. After removing
excess DHE, cells were suspended in PR-free DMEM containing Aβ42,
PMA, apocynin (Apo), Apo+Aβ42, and Apo+PMA for 1 h prior to
taken images.
Fluorescence microscopy for DHE was performed with a Nikon
TE-2000 U ﬂuorescence microscope and a 40×, NA 0.95 objective lens.
Images were acquired using a cooled CCD camera controlled by a
computer running a MetaVue imaging software (Universal Imag-
ing, PA). The ﬂuorescence excitation source was controlled with a
Uni-Blitz mechanical shutter. For image acquisition, a short exposure
time (100 ms) and low intensity excitation light were applied to
minimize photo-bleaching. The ﬂuorescent intensity of DHE in each
cell was quantiﬁed by integrating the pixel-intensity of the cell.
Background subtraction was done for each image prior to the quan-
tiﬁcation of DHE intensity of cells. Each experiment was repeated
three times for statistical data analysis.
2.8. Western blot analysis
DITNC cells were cultured in 60-mm dishes until 90% con-
ﬂuent. After treatment as described above, cells were washed with
ice-cold PBS twice and 200 μl cell lysate medium (62.5 mM Tris–HCl,
pH 6.8, 2% w/v SDS, 10% glycerol, 50 mM dithiothreitol, 0.01% w/v
bromophenol blue) were added. After collecting the cell lysate, pro-
tein concentrations were determined by the Bradford assay [26].
Equivalent amounts of protein for each sample were applied to 7.5%
SDS-PAGE. After electrophoresis, proteins were transferred to nitro-
cellulose membranes (0.45 μm, Bio-Rad). Membranes were incubated
in Tris-buffered saline, pH 7.4 with 0.5% Tween 20 (TBS-T) containing
5% non-fat milk for 1 h at room temperature. The blots were reacted
with primary rabbit anti-cPLA2 or anti-p-cPLA2 or anti-lamin A/C
(1:1000; Cell Signaling) at 4 °C overnight with gentle shaking. After
washing with TBS-T, the membranes were incubated with goat anti-
rabbit IgG-HRP (1:2000; Sigma) for 1 h at room temperature and
then washed 3× with TBS-T. Proteins were detected and visualized
by enhanced chemiluminescence using a SuperSignal West Pico
Chemiluminescent Detection Kit (Pierce Biotechnology, Inc). cPLA2
and p-cPLA2 bands were detected at 105 kDa.
2.9. Statistical analysis
Data are presented as mean±SD from at least three independent
experiments. Comparisons between groups were made with one-way
ANOVA, followed by Bonferroni's post hoc tests. Comparison between
two groups was made with paired t test. Values of pb0.02 are con-
sidered statistically signiﬁcant.3. Results
3.1. Oligomeric Aβ42 induced temporal membrane biphasic changes in
DITNC cells through NADPH oxidase
We applied the ﬂuorescencemicroscopy of Laurdan integrated into
plasma membranes of astrocytic DITNC cells to study the possible
changes in membrane phase properties induced by oligomeric Aβ42.
Since Laurdan possesses both an electron donor and an electron
receptor, ﬂuorescent excitation can induce a large excited-state dipole.
This strong dipole tends to locally align the surrounding molecules
(e.g. water), which dissipates a small fraction of the excited state
energy and produces a red shift in the emission spectrum. A
molecularly-disordered membrane allows more water molecules to
partition into the membrane core, which is manifested by a red shift
of Laurdan's emission maximum [23,27]. To quantify this shift,
Gratton and co-workers [27] have deﬁned the generalized polariza-
tion (GP) which was applied to observe phase transitions of differ-
ent lipid membranes [28,29] as well as cell membranes [24,30]. A
higher GP value indicates a more molecularly-ordered membrane,
while a lower GP value indicates a more molecularly-disordered
membrane. It has also been proved that once it is integrated into
the plasma membranes of astrocytes, it would be unlikely to diffuse
further into the intracellular organelles due to the hydrophobic
properties of Laurdan [24].
Pseudo-colored GP-mapped images were reconstructed for direct
observation of changes in GP values at different time points in cells
after treatment with 1 μM of oligomeric Aβ42 (Fig. 1A). In our data
analysis, we plotted GP–GPo, where GPo is the GP of control ex-
periment (i.e. no Aβ42 treatment). Therefore, GP–GPo of the control is
always zero, serving as a common reference datum. Fig. 1B shows that
Aβ42 oligomers made cell membranes become more molecularly-
disordered within 30 min, as indicated by negative GP–GPo values.
However, these GP–GPo values became more positive with time and
was more molecularly-ordered compared to the control at 3 h after
the oligomeric Aβ42 treatment, as indicated by a positive GP–GPo
value. In order to test whether oxidative stress induced by NADPH
oxidase plays a role in the time-dependent changes in GP values,
apocynin, was used to pretreat cells for 1 h followed by the treat-
ment with oligomeric Aβ42. Apocynin is an intracellular inhibitor
of the NADPH oxidase assembly, and it inhibits the translocation of
the cytosolic oxidase subunits p47-phox and p67-phox to the mem-
brane fraction [31]. In the presence of apocynin, the GP–GPo values
were negative, indicating more molecularly-disordered membranes
(Fig. 1C). These results suggest that the activation of NADPH oxidase
is required for oligomeric Aβ42 to make DITNC cell membranes be-
come more molecularly-ordered.
The treatment of Aβ42 for cells not only affected the overall
(macroscopic) changes in GP (i.e. GP–GPo), but it also altered the
distribution of GP. Fig. 1D (upper) shows GP ranging from −0.4 to 0.4
with a peak at GP≈−0.14. After treatment with Aβ42 for 30 min,
the population of high GP values was decreased, and the peak was
found at GP≈−0.25 (Fig. 1D, middle). However, after treatment with
Aβ42 for 3 h, the population of high GP increased with two major
peaks at GP=−0.06 and GP=0.1, which was suppressed by Apo (data
not shown).
3.2. Oligomeric Aβ42 caused artiﬁcial membranes made of rat brain lipid
extract to become more molecularly-disordered
To rule out the factors of cellular processes contributing to Aβ42-
mediated changes in the molecular order of membranes, we exam-
ined changes in artiﬁcial membranes made of rat brain lipid extract.
Fig. 2A showed that oligomeric Aβ42 caused artiﬁcial membranes
to become more molecularly-disordered, as indicated by negative
GP–GPo values. For a negative control, we examined if the reversed
Fig. 2. Aβ42 caused vesicle membranes of rat brain lipid extract to become more
molecularly-disordered. (A) The GP–GPo (GPo=−0.24±0.085, is the GP of control sample
without treatment at time=0) of Laurdan integrated invesiclemembranes of rat brain lipid
extract after Aβ42 treatment exhibited only negative values, indicating more molecularly-
disorderedmembranes. (B) The reversed amino acid sequence of Aβ, Aβ42−1, had no effect
on the GP–GPo value. (⁎p< 0.02) (C) The GP distribution after treatments with Aβ1−42 and
Aβ42−1; without treatment (upper); treatmentwith Aβ1−42 for 1 h (middle); treatmentwith
Aβ42−1 for 1 h (lower).
Fig. 1. Aβ42 induced temporal biphasic changes of membrane molecular order in
DITNC cells. (A) Pseudo-colored GP-mapped images of DITNC cells were reconstructed
based on the GP value of each pixel. Control (left); a GP-mapped image taken at 0.5 h
after treatment with 1 μM of Aβ42 (middle); a GP-mapped image acquired at 3 h after
treatment with 1 μM of Aβ42 (right). (B) The GP–GPo (GPo=−0.0030±0.016, is the GP
of control sample without Aβ42 treatment at time=0) exhibited a negative value at
0.5 h after Aβ42 treatment to cells, indicating more molecularly-disordered mem-
branes, but a positive value at 3 h, indicating more molecularly-ordered mem-
branes. (C) The GP–GPo (GPo=0.074±0.0051, is the GP of control sample treated with
Apocynin (1 mM) in DMSO) exhibited only negative values in cells pretreated with
apocynin (1 mM) for 1 h followed by Aβ42 (1 μM) treatment. (D) Changes of GP
distribution in response to the treatment of cells with Aβ42; without treatment (upper);
treatment with Aβ42 for 30 min (middle); treatment with Aβ42 for 3 h (lower).
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membranes made of brain lipid extract. Fig. 2B shows that Aβ42−1 only
induced small changes in the molecular order of artiﬁcial membranes,
and the changes were experimentally insigniﬁcant. These results are
consistent with the notion that Aβ42 directly interacts with mem-branes making them more molecularly disordered [32]. These results
also lead to the hypothesis that Aβ42 makes cell membranes become
more molecularly-ordered through intracellular signaling pathways,
which probably requires a long time (as shown in Fig. 1, it took more
than 3 h for cell membranes to become more molecularly-ordered).
3.3. Oligomeric Aβ42 increased superoxide anion production and
phosphorylation of cPLA2 through NADPH oxidase
To test the hypothesis that NADPH oxidase and cPLA2 are in-
volved in the Aβ42-induced membrane biphasic changes in DITNC
cells, we ﬁrst examined whether oligomeric Aβ42 increases super-
oxide anion (O2−) production and phosphorylation of cPLA2 through
Fig. 3. Aβ42 increased superoxide anion production through NADPH oxidase in DITNC
cells. The ﬂuorescent intensity of DHE was measured as an indicator of the superoxide
anion (O2−) production level in cells. (⁎p<0.02) Apocynin suppressed the O2− production
induced by Aβ42, supporting that Aβ42 increases O2− production in DITNC cells through
NADPH oxidase.
2516 J.B. Hicks et al. / Biochimica et Biophysica Acta 1778 (2008) 2512–2519NADPH oxidase in DITNC cells. We found that oligomeric Aβ42 in-
creased the production of O2− in DITNC cells, as indicated by increased
ﬂuorescent intensity of DHE. The increase of DHE intensity was sup-
pressed by the inhibitor of NADPH oxidase, apocynin (Fig. 3). For a
positive control, we treated cells with the phorbol ester (PMA), which
has been reported to increase the production of superoxide anions in
astrocytes through NADPH oxidase [33].
Western blot analysis of phosphorylated cPLA2 (p-cPLA2) shows
that oligomeric Aβ42 (1 μM) increased the immunoreactivity of
p-cPLA2 in DITNC cells, and this effect was suppressed by apocynin
(Fig. 4). Since apocynin was dissolved in DMSO, DMSO alone was
not able to trigger phosphorylation of cPLA2. These results are con-
sistent with our previous reported with primary astrocytes [17].
However, the response of DITNC cells to Aβ42 treatment is slower
as compared with that of primary astrocytes.Fig. 4. Aβ42 increased immunoreactivity of p-cPLA2 in a time-dependent manner.
DITNC cells were stimulated with Aβ42 (1 μM) for different incubation times and were
subjected to Western blot analysis with anti-p-cPLA2 and anti-cPLA2 antibody. Results
were from one representative experiment (upper). Repeated experiments gave simi-
lar results. For each sample, the relative intensity of phosphorylated cPLA2 was normal-
ized by the total cPLA2 (lower). Values are the mean of three independent experiments.
(⁎p<0.02)3.4. cPLA2 was the key enzyme involved in Aβ42-induced membrane
biphasic changes
Inhibitors of PLA2 were applied to study the involvement of PLA2
in Aβ42-induced membrane changes in DITNC cells. When the in-
hibitor of cPLA2 and calcium-independent PLA2 (iPLA2), methyl
arachidonyl ﬂuorophosphonate (MAFP), was added to cells and fol-
lowed by treatment with Aβ42, the GP–GPo values only exhibited
negative numbers (Fig. 5, left), indicating more molecularly-disor-
dered membranes, and the ability of Aβ42 to make membrane become
more molecularly-ordered as indicated by a positive GP–GPo value
at 3 h in Fig. 1B was totally abrogated in Fig. 5, left. However, the
speciﬁc inhibitor of iPLA2, bromoenol lactone (BEL), was incapable of
suppressing the membrane biphasic changes induced by oligomeric
Aβ42 (Fig. 5, right), which ruled out the role of iPLA2. These results
suggested that cPLA2 (but not iPLA2) was the key enzyme involvedFig. 5. Effects of PLA2 inhibitors on Aβ42-induced membrane changes in the molecular
order. The membrane biphasic order changes induced by Aβ42 (1 μM) was totally
suppressed by MAFP (5 μM) as indicated by GP–GPo values (GPo=0.074±0.06, is the GP
of control cells pretreated with 5 μM of MAFP in DMSO) exhibiting negative numbers
only (left), but was not suppressed by BEL (5 μM) (GPo=−0.059±0.018, is the GP of
control cells pretreated with 5 μM of BEL in DMSO) (right). (B) GP distribution after
treatment with Aβ42 for cells pretreated with MAFP (left) and BEL (right).
2517J.B. Hicks et al. / Biochimica et Biophysica Acta 1778 (2008) 2512–2519in makingmembranes becomemoremolecularly-ordered as observed
in the biphasic changes of DITNC cell membranes induced by oligo-
meric Aβ42.
The distribution of GP in Fig. 5B, (lower right) shows that BEL was
incapable of suppressing the increased population of high GP domains
with a peak at GP≈0.1, whereasMAFP totally suppressed the formation
of high GP domains (Fig. 5B, lower left). These results directly dem-
onstrate that Aβ42 makes membranes become more disordered, but
also activates cPLA2, resulting in the formation of high GP domains.
3.5. The hydrolyzed products of cPLA2 made cell membranes become
more molecularly-ordered
When cPLA2 is activated, it targets and hydrolyzes phospholipids
in cell membranes, resulting in hydrolyzed products, such as arachi-
donic acid (AA) and lysophosphatidylcholine (LPC). Since these
hydrolyzed products of cPLA2 may also contribute to the change of
membranemolecular order induced by oligomeric Aβ42 in DITNC cells,
we applied the ﬂuorescence microscopy of laurdan integrated in
membranes of DITNC cells to study possible membrane changes
caused by AA and LPC. We found that AA made membranes of DITNC
cells more molecularly-ordered, as indicated by positive GP-GPo val-
ues; whereas LPC did not cause signiﬁcant changes of membranes.
Similarly, LPC did not cause any major effect on the GP distribution
(Fig. 6, right). However, AA made signiﬁcant changes in the distri-
bution of GP (Fig. 6, left) and produced two major populations with
their peaks at GP≈−0.1 and GP≈0.025.Fig. 6. Effects of hydrolyzed products of cPLA2 on membranes in DITNC cells. (A) The
treatment with arachidonic acid (AA) for 1 h caused cell membranes to become
more molecularly-ordered, as indicated by positive GP–GPo values. (B) The treatment
with lysophosphatidylcholine (LPC) for 1 h did not cause a signiﬁcant change in GP.
(⁎p<0.02) (GPo=−0.038±0.016 is the GP of control cells treated with ethanol, as both
AA and LPC were dissolved in ethanol.) (C) GP distribution of DITNC cell membranes
treated with AA (left) and LPC (right).4. Discussion
Applyingﬂuorescencemicroscopyof Laurdan integrated intomem-
branes of astrocytic DITNC cells and artiﬁcial membranes made of rat
brain lipid extract, we demonstrated that both NADPH oxidase and
cPLA2 were involved in the Aβ42 oligomer-induced temporal biphasic
membrane change in DITNC cells. Our data also suggest that a hydro-
lyzed product of cPLA2, arachidonic acid (AA), contributes to the effect
of Aβ42 in causing cell membranes to become more molecularly-
ordered through the activation of NADPH oxidase and cPLA2.
The absolute changes of GP in artiﬁcial membranes made of
whole brain lipid extract induced by Aβ42 was about 0.4 (Fig. 2A),
which was greater than that in Aβ42-stimulated DITNC cells, where
the maximum absolute change of GP can be estimated from the GP's
at time points 0.5 h and 3 h to be about 0.1 (Fig. 1B). Fig. 1C also
shows that the absolute change of GP in Aβ42-stimulated cells
pretreated with Apo to inhibit NADPH oxidase and cPLA2 was about
0.04. Generally, the changes of GP in cells induced by Aβ42 are
smaller, as compared to those in artiﬁcial membranes, but they are
statistically signiﬁcant. In fact, the GP changes in DITNC cells mea-
sured here are comparable to the GP change (∼0.13) in macrophages
induced by removal of cholesterol with methyl β-cyclodextrin
(mβCD) [34]. We observed that the GP's of controls (i.e. GPo) did not
change with time, but varied with different experiments, which is
probably due to different inhibitors (e.g. Apo, MAFP, and BEL) being
added to different controls, as these inhibitors contribute slightly to
the emission at the wavelengths of 446 and 499 nm tested in PBS
(data not shown).
In fact, a correlation between GP values and raft/non-raft domains
has been established using liposomes with equal molar ratios of
dioleoylphosphatidylcholine (DOPC), cholesterol, and sphingomyelin
by Dietrich et al., 2001 [35]. Our GP distribution of artiﬁcial mem-
branes made of whole brain lipid extract (Fig. 2C, upper) is compar-
able to that reported by Dietrich et al., 2001 [35]. GPN0.55 andb−0.05
were found to represent membranes in gel and ﬂuid phase, respec-
tively. Moreover, (−0.05bGPb0.25) and (0.25bGPb0.55) represent
membranes in liquid-disordered/nonraft domains and liquid-ordered/
raft domains, respectively [35]. Separation of liquid-ordered and
liquid-disordered phases has also been shown at GP values between
0.2 and 0.3 [36,37]. The GP values of cell membranes ranging from −0.4
to 0.4 reported here clearly provide evidence of a coexistence of both
liquid-disordered/nonraft and liquid-ordered/raft domains. Interest-
ingly, Aβ42-induced cPLA2 activation produced a major population of
high GP domains with a peak at GP=0.1 and a GP range of −0.1 to 0.4
(Fig. 1D, lower, and Fig. 5B, right lower). Since the GP of Lubrol-
insoluble membranes at 37 °C has been reported to be 0.308±0.126
[34], these results suggest that Aβ42-induced cPLA activation in DITNC
cells increases raft heterogeneity and phase separation in membranes.
The distributions of GP (Fig. 1D, lower, and Fig. 5B, right lower)
observed in Aβ42-induced cPLA2 activation are similar to those
reported GP distribution in macrophage membranes at 37 °C [34].
Since macrophages are relatively active immune cells in which cPLA2
can be frequently activated [38], we speculate that the GP distributions
in macrophage membranes reported by Gaus et al., [34] might be
affected in part by cPLA2 activation.
In model membranes, areas of high curvature exhibit lower GP
values than areas of low curvature [36]. However, for cell membranes
similar differences in physical arrangement may not account for
comparable changes in GP. It has been shown in living macrophages
that variable surface morphologies, cell-to-cell contacts, and possible
adhesion locations are enriched in high GP domains, and these high
GP domains are likely a result of condensed membrane structure as
opposed to differences in curvature [34]. In agreement with these
results, our GP-mapped images of Aβ42-stimulated DITNC cells
(Fig. 1A) show an increase in high GP domains at cell edges, im-
plicating local compositional changes, rather than differences in
2518 J.B. Hicks et al. / Biochimica et Biophysica Acta 1778 (2008) 2512–2519curvature, as being responsible for the observed increase in high GP
domains at these locations.
It is also important to note that PLA2 exerts a unique effect on
bilayer membranes. While PLA2 causes membranes to become more
molecularly-ordered as measured by Laurdan [39], surprisingly, it has
also been reported that it causes membranes to become more
ﬂuidized [12,40–42]. More rigorously, Laurdan is a measure of de-
fects in molecular packing of bilayer membranes which accommo-
date water molecules (i.e. water partition). Other membrane probes,
such as 1,6-diphenyl-1,3,5-hexatriene (DPH), 1-(4-trimethylammo-
niumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), and molecular
rotor, (2-carboxy-2-cyanovinyl)-julolidine farnesyl ester (FCVJ), mea-
sure rotational motions of the probes, which reﬂects the size of free
volume for diffusion. Therefore, the unique effect of PLA2 on cell
membranes suggests that lower water partitioning into membranes
may not necessarily result in lower membrane ﬂuidity. Clearly, more
investigations are needed to examine the relationship between
water partitioning into membranes and free volume in membranes.
Since both Aβ42 and PLA2 cause membrane to become more ﬂuidized,
Aβ42 does not produce a temporal biphasic change of membrane
ﬂuidity in DITNC cells (data not shown); therefore, ﬂuidity study
may not be able to probe the cPLA2 pathway underlying the effect of
Aβ42 on membranes in DITNC cells.
The release of Aβ from its precursor protein (amyloid precursor
protein) and its pathway leading to deposition of amyloid plaques
have been regarded to play an important role in the etiology of AD
[1,43]. Recent studies have demonstrated cytotoxic effects of Aβ,
especially its aggregation to the oligomeric form [44]. These soluble
diffusible protoﬁbrils of Aβ have been shown to disrupt mem-
branes, forming calcium channels [3] and causing increase in calcium
inﬂux [45] and triggering cell death pathways [3,45,46]. These prop-
erties of Aβ have induced interest in investigation of how Aβ aggre-
gates impact on cell membrane properties.
Studies with synthetic membranes indicated the ability of oligo-
meric Aβ to perturb cholesterol containing membranes [2,47]. A
number of studies indicated alteration of membrane ﬂuidity by solu-
ble Aβ [30,32,48–53]. In our study, we investigate cell membrane
molecular order changes induced by oligomeric Aβ in DITNC cells,
which allow us to address membrane changes not only due to the
direct interaction of Aβ42 oligomers with membranes, but also due to
Aβ42-triggered cellular processes.
Increase in oxidative stress has been regarded to play a role in the
development of AD [54]. It has been reported that Aβ42 increases the
production of reactive oxygen species (ROS) in astrocytes through
the superoxide producing enzyme, NADPH oxidase [17,55]. Oxidative
stress has also been reported to trigger the MAPK pathways and
subsequent activation of PLA2 (Xu et al., 2002; Zhu et al., 2005). The
relationship between cPLA2 and NADPH oxidase under oxidative con-
ditions has also been demonstrated in phagocytic cells [56–61]. In
neutrophils, cPLA2 was found in cytoplasm and plasma mem-
branes, suggesting multiple role of this enzyme in regulating different
subcellular membranes [62]. In this study, Aβ42 oligomers activated
NADPH oxidase and cPLA2 in astrocytes, resulting in increased ROS
production. In addition, this condition rendered astrocyte mem-
branes to become more molecularly-ordered.
Immortalized rat astrocytes, DITNC cells, possess the phenotypic
characteristics of type 1 astrocytes [63]. Similar to the ﬁnding with
primary astrocytes [17], Aβ42 induced ROS in DITNC cells and ROS
production was inhibited by apocynin, a speciﬁc inhibitor for NADPH
oxidase (Fig. 3). Aβ also increased phosphorylation of cPLA2 in DITNC
cells (Fig. 4). The ability for apocynin to inhibit Aβ-mediated cPLA2
phosphorylation suggests a link between ROS and cPLA2 activation
through NADPH oxidase. However, it is interesting to note that
DITNC cells respond to Aβ42 stimulation much slower than primary
astrocytes. While primary astrocytes took less than 15 min to activate
cPLA2 by Aβ42 oligomers [17], DITNC cells took more than 1 h. Theprolonged responsive time of DITNC cells provides an advantage
allowing a longer time window for the examination of signaling
pathways and measurement of cell membrane property changes. This
unique feature provided advantage for using DITNC cell culture as a
good cell model for study of astrocytes in neurodegenerative diseases.
Oligomers of Aβ42, but not the monomeric peptide, has been re-
ported to insert into cholesterol-containing phosphatidylcholine
monolayers with an anomalously low molecular insertion area [2].
Consistent with the effect of Aβ42 oligomers on artiﬁcial mem-
branes made of rat brain lipids and membranes of DITNC cells within
the ﬁrst hour reported here, Aβ42 oligomers have an enhanced dis-
ordering effect on membranes [32]. However, in membranes from
brain lipids, Aβ42 monomers render these artiﬁcial membranes to
become more molecularly ordered [64]. Aβ42 assembly at the bilayer
surface is dependent on cholesterol, but does not result in bilayer
disruption [64]. In our study, we observed a time-dependent
transition of the DITNC membrane to become more molecularly-
ordered upon incubationwith Aβ oligomers. A similar time course for
activation of cPLA2 was observed (Fig. 4). Our results are consistent
with study with erythrocytes in which secretory PLA2 also renders
these membranes to be more molecularly-ordered [39], and are
consistent with the ﬁnding by others that arachidonic acid makes
membranes become more molecularly-ordered [65].
Increasing evidence has been cumulated to suggest that oligo-
merization of amyloid peptides leads to alteration of cell membranes
and cell signaling pathways. There are other examples in which pro-
tein misfolding is an important part of disease processes. For example,
amylin, a molecule in Type II diabetes, also binds and disrupts mem-
branes of insulin-producing β-cells [66]. There is further support that
amylin can activate NADPH oxidase to increase ROS production in
β-cells [67]. In the study here, we have demonstrated that NADPH
oxidase and cPLA2 are involved in the Aβ42-oligomer-induced mem-
brane biphasic change in astrocytic DITNC cells. Understanding the
mechanism underlying cell membrane alterations induced by Aβ42
should prove further our understanding in alteration of primary
functions of membrane proteins and in the pathogenesis of AD.
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